Chengdu Kanghua Biological Products Co.,Ltd.

Epidemic cerebrospinal meningitis is acute infectious disease caused by meningococcus, which can be spread by through coughing, sneezing, spitting in the air.

The product “Group ACYW135 Meningococcal Polysaccharide Vaccine”, also commercially named “Mai Ke Xin”, has been researched for years under the guidance of the standards by Council of Europe. The characteristics of this product as follows:

Safety: The incidence rate of local adverse events <10/100,000;
Effectiveness: High immunogenicity and seropositivity rate;
Applicability: Protect against meningococcal group W135 and Y bacteria, and strengthen the immunogenicity of immunized people against meningococcal group A and C.